| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |